GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Policy Acquisition Expense

Acticor Biotech (XPAR:ALACT) Policy Acquisition Expense


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Acticor Biotech (XPAR:ALACT) Business Description

Traded in Other Exchanges
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.